These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16644471)

  • 1. Therapeutic targeting of pattern-recognition receptors.
    Rezaei N
    Int Immunopharmacol; 2006 Jun; 6(6):863-9. PubMed ID: 16644471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dectin-1: a signalling non-TLR pattern-recognition receptor.
    Brown GD
    Nat Rev Immunol; 2006 Jan; 6(1):33-43. PubMed ID: 16341139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids.
    Lee JY; Zhao L; Hwang DH
    Nutr Rev; 2010 Jan; 68(1):38-61. PubMed ID: 20041999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
    Kanzler H; Barrat FJ; Hessel EM; Coffman RL
    Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.
    Mitchell JA; Paul-Clark MJ; Clarke GW; McMaster SK; Cartwright N
    J Endocrinol; 2007 Jun; 193(3):323-30. PubMed ID: 17535871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors.
    Albiger B; Dahlberg S; Henriques-Normark B; Normark S
    J Intern Med; 2007 Jun; 261(6):511-28. PubMed ID: 17547708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].
    Kabelitz D
    Med Monatsschr Pharm; 2012 Jul; 35(7):238-44. PubMed ID: 22852274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE; Xu M; Koski GK; Czerniecki BJ
    Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G; Kuznik A; Jerala R
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.
    Jo EK
    Curr Opin Infect Dis; 2008 Jun; 21(3):279-86. PubMed ID: 18448973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.
    Jo EK; Yang CS; Choi CH; Harding CV
    Cell Microbiol; 2007 May; 9(5):1087-98. PubMed ID: 17359235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches in immunotherapy.
    Thomas PG; Doherty PC
    Science; 2010 Jan; 327(5963):249. PubMed ID: 20075216
    [No Abstract]   [Full Text] [Related]  

  • 14. Toll-like receptor signalling and the clinical benefits that lie within.
    Verstak B; Hertzog P; Mansell A
    Inflamm Res; 2007 Jan; 56(1):1-10. PubMed ID: 17334664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor function and signaling.
    Kaisho T; Akira S
    J Allergy Clin Immunol; 2006 May; 117(5):979-87; quiz 988. PubMed ID: 16675322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of TLR expression, a new perspective for the role of VIP in immunity.
    Gomariz RP; Arranz A; Juarranz Y; Gutierrez-Cañas I; Garcia-Gomez M; Leceta J; Martínez C
    Peptides; 2007 Sep; 28(9):1825-32. PubMed ID: 17706836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
    Chinenov Y; Rogatsky I
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
    Doyle SL; O'Neill LA
    Biochem Pharmacol; 2006 Oct; 72(9):1102-13. PubMed ID: 16930560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular regulation of inflammation and cell death.
    Yeretssian G; Labbé K; Saleh M
    Cytokine; 2008 Sep; 43(3):380-90. PubMed ID: 18703350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs targeting Toll-like receptors.
    Krishnan J; Lee G; Choi S
    Arch Pharm Res; 2009 Nov; 32(11):1485-502. PubMed ID: 20091261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.